Loading clinical trials...
Loading clinical trials...
Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in Acute Myocardial Infarction (AMI) Patients With Abnormal Glucose Metabolism: a Multicenter Prospective Randomized Clinical Trial
Conditions
Interventions
Pitavastatin
Atorvastatin
Locations
1
China
Fuwai Hospital
Beijing, Beijing Municipality, China
Start Date
October 1, 2015
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2023
Last Updated
May 12, 2022
NCT06744322
NCT06788275
NCT05292404
NCT06118281
NCT07042321
NCT06995495
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions